14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.25 $4.76 Friday, 3rd May 2024 AVXL stock ended at $3.85. This is 2.39% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.19% from a day low at $3.82 to a day high of $3.98.
90 days $3.25 $6.15
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Jan 22, 2021 $5.70 $6.14 $5.68 $6.11 1 076 092
Jan 21, 2021 $5.84 $5.90 $5.56 $5.75 542 926
Jan 20, 2021 $6.04 $6.06 $5.66 $5.82 732 178
Jan 19, 2021 $5.98 $6.08 $5.79 $5.98 801 061
Jan 15, 2021 $6.04 $6.24 $5.72 $5.82 804 572
Jan 14, 2021 $5.64 $6.09 $5.64 $5.92 861 686
Jan 13, 2021 $5.50 $5.77 $5.45 $5.63 633 808
Jan 12, 2021 $5.55 $5.65 $5.42 $5.53 468 094
Jan 11, 2021 $5.70 $5.71 $5.50 $5.60 674 766
Jan 08, 2021 $5.57 $5.78 $5.54 $5.64 516 964
Jan 07, 2021 $5.49 $5.62 $5.40 $5.58 506 422
Jan 06, 2021 $5.17 $5.57 $5.17 $5.46 985 392
Jan 05, 2021 $5.28 $5.35 $5.12 $5.17 611 458
Jan 04, 2021 $5.45 $5.52 $5.12 $5.29 825 673
Dec 31, 2020 $5.43 $5.68 $5.31 $5.40 965 525
Dec 30, 2020 $5.60 $5.70 $5.37 $5.49 840 328
Dec 29, 2020 $5.55 $5.74 $5.26 $5.51 1 334 182
Dec 28, 2020 $5.94 $6.05 $5.48 $5.63 1 728 870
Dec 24, 2020 $6.02 $6.02 $5.62 $5.75 575 017
Dec 23, 2020 $6.12 $6.19 $5.74 $5.85 1 108 278
Dec 22, 2020 $6.50 $6.62 $5.98 $6.04 1 369 077
Dec 21, 2020 $6.05 $6.61 $5.92 $6.49 1 330 224
Dec 18, 2020 $6.44 $6.50 $6.05 $6.05 1 534 082
Dec 17, 2020 $5.77 $6.50 $5.73 $6.39 1 880 786
Dec 16, 2020 $5.95 $5.95 $5.39 $5.80 2 398 832
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT